BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05456191-completion@plaintrial.com
DTSTAMP:20261028T184913Z
DTSTART;VALUE=DATE:20310707
SUMMARY:A Study to Investigate Tolerability and Efficacy of Asciminib (Oral
 ) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With 
 Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leuke
 mia in Chronic Phase (Ph+ CML-CP) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05456191
URL:https://plaintrial.com/trial/NCT05456191
END:VEVENT
END:VCALENDAR